CSPC Pharmaceutical Group (HKG:1093) plans to further buy back shares on the market for up to HK$5 billion including the buyback plan of HK$1 billion approved earlier.
The company has already utilized HK$773 million of the HK$1 billion buyback plan to repurchase 163,860,000 shares as of Thursday, a same-day filing with the Hong Kong Exchange said.
The bought-back shares will be cancelled, the disclosure said.
CSPC Pharmaceutical Group had already repurchased shares for HK$387 million in the first half of this year.
Shares of the company rose 1% at close of Thursday trade.
Price (HKD): $4.69, Change: $+0.040, Percent Change: +0.86%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。